NIBSC - 18th SoGAT Meeting

Enter a search term

Home Page > Spotlight > Standardisation of Genome Amplification Techniques > Blood virology > Past meetings > 18th SoGAT Meeting

18th SoGAT Meeting

Return to previous page|

May 2005 Presentations

Speaker	Title of Talk	Presentation
Cindy WalkerPeach, Ph.D. Director, Development and Operations Ambion Diagnostics	Extending the Armored RNA Technology to DNA	View Presentation
Darren Jardine and Staff of the National Serology Reference Laboratory, Australia	Quality Assessment for Blood Screening Laboratories in Australia and the Asian Pacific.	View Presentation
Dirk Heckel, PhD Diagnostic Sample Preparation and Stabilization QIAGEN GmbH	Standardization of Automated Sample Preparation for Viral Diagnostics	View Presentation
Dominique Challine Hôpital Henri Mondor, Créteil, France	Infectivity of Organ, Tissue and Cell Transplants in the Presence of Serological Markers of Hepatitis B Virus	View Presentation
Elwyn Griffiths Biologics and Genetic Therapies Directorate	World Health Organization International Biological Standards	View Presentation
Gordon Elliott Biotrin, 93 The Rise, Mount Merrion, Dublin, Ireland	Donor screening for parvovirus B19 antibodies: Reducing or eliminating the risk of transmission	View Presentation
Ewa Brojer Institute of Hematology and Blood Transfusion, Warsaw, Poland	The current status of HCV, HIV, HBV NAT screening	View Presentation
H.-P. Grunert Charité University Medicine Berlin	EQASs for Blood Borne Virus Genomes and BSE Prions from Cattle Brain and INSTAND Reference Materials	View Presentation
Harry Bos on behalf of Project Group Parvo B19 Safe Blood Components	Anti-B19 screening for safe cellular blood products for at–risk patients	View Presentation
Harvey Holmes National Institute for Biological Standards and Control (NIBSC)	SoGAT and HIV NAT Standards - 2nd International Standard for HIV-1 RNA	View Presentation
Hiroshi YOSHIZAWA Hiroshima University, Hiroshima, Japan	HBV screening Further improvement of blood safety	View Presentation
Jean-Pierre Allain	Natural history of HBV infection	View Presentation
Marco Koppelman Sanquin Diagnostic Services, Amsterdam	Validation of HCV-RNA detection in small test pools on cadaveric samples	View Presentation
M. Rios CBER/FDA	Development of Standard Reagents for WNV NAT	View Presentation
Mark Manak, Ph.D. BBI Diagnostics, Inc.	Linearity Panels HIV RNA, HCV RNA, HBV DNA, and CMV DNA	View Presentation
Marta José, Rodrigo Gajardo and Juan I. Jorquera Instituto Grifols S.A., Barcelona, SPAIN	Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples stored at different temperatures	View Presentation
Masahiro Satake Tokyo Metropolitan Red Cross Blood Center	Lookback study for transfusion-related HBV infection in Japan	View Presentation
Matthias Gessner Baxter AG, Vienna, Austria	Trust is good, control is better!	View Presentation
Michael Chudy Paul-Ehrlich-Institut	Correlation of HBsAg and HBV DNA	View Presentation
MP Busch NHLBI-REDS NAT Study Group	Relative Sensitivities of US Licensed NAT Assays for Detection of Viremia in Early HIV and HCV Infection	View Presentation
Paul D. Neuwald, PhD AcroMetrix Corporation, Benicia, CA	MP Busch NHLBI-REDS NAT Study Group	View Presentation
R.I. Wielgosz BIPM	JCTLM Approach to Higher Order Standards	View Presentation
John Saldanha Roche Molecular Systems, Pleasanton, CA, USA	Feasibility of Synthetic Materials as Primary Standards	View Presentation
Sally Baylis NIBSC	Standardisation of P. falciparum HBV, HCV and NAT	View Presentation
Susan E. Bromley, Ph.D.Director, Product Development, Bayer Healthcare Diagnostics	Development and Characterization of Synthetic Standards: HCV RNA	View Presentation
Theo Cuypers Sanquin	Are conversion factors to international units assay related?	View Presentation
Theo Cuypers Sanquin	Presence (absence) of genotype 2 and 3 Erythrovirus DNA in manufacturing plasma	View Presentation
Thomas Laue	Full characterization of HAV RNA window period positive blood donations in Germany	View Presentation
Yoshiaki Okada National Institute of Infectious Disease	B19 inactivation by heat treatment with epithelial cell lines	View Presentation

18th SoGAT Meeting

May 2005 Presentations

Speaker

Title of Talk

Presentation